Helo Corp Announces Annual 2023 Results
Helo Corp Announces Annual 2023 Results
DUBLIN, IRELAND / ACCESSWIRE / April 24, 2024 / Helo Corp. (OTC PINK:HLOC) ("Helo" or the "Company"), a data-driven wellness technology company, announces its annual 2023 results.
爱尔兰都柏林/ACCESSWIRE /2024年4月24日/Helo公司。(OTC PINK:HLOC)(“Helo”或“公司”),一家基于数据的健康科技公司,发布了其2023年度财报。
Helo Corp Annual Results
Helo公司年度财报
2023 | 2022 | Change | ||||||||||
Revenue from Continuing Operations |
$ | 4,553,764 | $ | 1,221 | NM | |||||||
Revenue from Discontinued Operations |
$ | 2,899,378 | $ | 31,320,280 | NM | |||||||
Total Revenue |
$ | 7,453,142 | $ | 31,321,501 | (76)% | |||||||
Cost of Goods Sold* |
$ | 3,146,350 | $ | 7,031,066 | (55)% | |||||||
Gross Profit* |
58% | 78% | (25)% | |||||||||
SG&A* |
$ | 8,679,374 | $ | 25,266,079 | (66)% | |||||||
Operating Loss* |
$ | (4,372,582) | $ | (975,644) | 348% | |||||||
Operating Margin* |
(59)% | (3)% | NM | |||||||||
Net Income (Loss)* |
$ | 8,783,435 | $ | (463,731) | NM | |||||||
EPS - Basic* |
$ | 0.10 | $ | 0.00 | NM | |||||||
EPS - Diluted* |
$ | 0.03 | $ | 0.00 | NM |
2023 | 2022 | 变更 | ||||||||||
持续经营业务收入 |
$ | 4,553,764 | $ | 1,221 | 未出现数据 | |||||||
已停业务收入 |
$ | 2,899,378 | $ | 31,320,280 | 未出现数据 | |||||||
总收入 |
$ | 7,453,142 | $ | 31,321,501 | (76)% | |||||||
营业成本* |
$ | 3,146,350 | $ | 7,031,066 | (55)% | |||||||
毛利润* |
58% | 78% | (25)% | |||||||||
销售、一般和行政管理费用* |
$ | 8,679,374 | $ | 25,266,079 | (66)% | |||||||
营业亏损* |
$ | (4,372,582) | $ | (975,644) | 348% | |||||||
营业利润率* |
(59)% | (3)% | 未出现数据 | |||||||||
净利润(亏损)* |
$ | 8,783,435 | $ | (463,731) | 未出现数据 | |||||||
每股收益 - 基本* |
$ | 0.10 | $ | 0.00 | 未出现数据 | |||||||
每股收益 - 稀释* |
$ | 0.03 | $ | 0.00 | 未出现数据 |
* - includes results from continuing and discontinued operations
* - 包括持续和终止业务的成果
NM - the percentage change was not meaningful
未出现数据 - 百分比变化无意义
"In 2023 and into 2024, we executed our restructuring initiatives to significantly reduce our cost structure, leverage our existing technology and refocus Helo on the development of our NutraMatic and Helo AIplatform," said Sean McVeigh, Chief Executive Officer. "As we are currently tight on cash, we are seeking additional capital to fund the development and launch of these exciting innovations, which we believe will position us for substantial growth."
“在2023年和2024年初,我们执行了重组措施,大幅降低了成本结构,利用现有的技术,将Helo重新聚焦于NutraMatic和Helo人工智能平台的开发,”首席执行官肖恩·麦克维(Sean McVeigh)说:“由于我们的现金非常紧张,我们正在寻求额外的资金来支持这些令人兴奋的创新产品的开发和推出,我们相信这将为我们带来巨大的增长。”
"2023 revenue from continuing operations was $4.6 million and from discontinued operations was $2.9 million, bringing our annual revenue for 2023 to $7.5 million, a decrease of 76% over the prior-year period," added David Ufheil, Chief Financial Officer. "Net Income for 2023 was $8.8 million, reflecting a $15.2 million increase in the fair value of VSC Coins that were issued to Helo in 2023, subject to a 24-month lock. We ended the year with total net assets of $19.1 million, and cash and cash equivalents of $0.3 million. The overall decline in results for 2023 reflects our shift in strategy to a new platform. In April 2024, we entered into an agreement to sell our Vyvo-focused subsidiaries. Accordingly, we have classified these operations as discontinued in our annual filing."
“2023年持续运营的营业收入为$460万,终止业务的营业收入为$290万,使我们的2023年年度营业收入达到$750万,较去年同期下降了76%,”首席财务官大卫·乌夫海尔(David Ufheil)补充道:“2023年的净利润为$880万,反映出在2023年发行给Helo的VSC Coins的公允价值增加了$1520万,但需要锁定24个月。我们在年底的总净资产为$1910万,现金及现金等价物为$30万。2023年业绩总体下降反映了我们的策略转变到新平台上。2024年4月,我们达成了出售Vyvo子公司的协议。相应地,我们在我们的年度报告中将这些业务分类为已终止。”
About Helo Corp.
关于Helo Corp.
Helo Corp. (OTC:HLOC) is a data-driven wellness technology company. Helo wearables and other smart devices are built on Helo's Life Sensing Technology, which uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters. Helo is developing the NutraMaticand Helo AI platform to leverage artificial intelligence and other technologies to analyze wearer data, provide personalized nutrition and recommendations, support the adoption of healthier lifestyle choices and drive human wellness transformation.
Helo Corp. (OTC:HLOC)是一家数据驱动的健康科技公司。Helo可穿戴设备和其他智能设备是基于Helo的生命感知技术构建的,该技术使用先进的传感器,增强的信号处理和算法来收集和处理特定的生物参数。Helo正在开发NutraMatic和Helo人工智能平台,利用人工智能和其他技术分析佩戴者数据,提供个性化的营养和建议,支持采用更健康的生活方式选择,并推动人类健康的转型。helocorp.comHelo正在开发Nutramatic,该产品使用最先进的传感器、增强信号处理和算法来收集和处理特定的生物参数。该公司的披露声明和基本报表可以在OTC: HLOC上找到。
For more information please visit helocorp.com.
如需更多信息,请访问OCT:HLOC.
The Company's disclosure statements and financial statements are available at OTC: HLOC.
公司的披露声明和财务报表可以在此处查阅:场外交易:HLOC.
Forward Looking Statements
前瞻性声明
This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "believes," and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management's current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company's filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
本新闻发布包含《证券法案》第27A条,经修订的《证券交易法案》第21E条及1995年美国私人证券诉讼改革法案所规定的"前瞻性声明"。这些前瞻性声明可通过"将要","相信"等语言表述进行识别。本新闻稿中所有除历史事实陈述外的语言均属于前瞻性声明且包含某些风险和不确定性因素,这些因素可能导致实际结果与前瞻性声明中的结果有所不同。这些前瞻性声明基于管理层对公司及公司所在行业的期望、假设、评估和预测,但涉及许多未知的风险和不确定性因素。有关这些及其他风险的详细信息已包含在公司提交给OTC市场和美国证券交易委员会的备案中。除非依照法律规定,公司无义务更新前瞻性声明以反映随后发生的事件或情况,以及其期望的变化。尽管公司认为这些前瞻性声明是合理的,但它不能保证这些期望会变成现实,实际结果可能与预期结果有所不同。我们敦促您在评估其中包含的前瞻性声明时,认真考虑这些因素,并注意不要过度依赖这些前瞻性声明,它们已完全受到这些警告性声明的限制。
Investors Contact:
investors@helocorp.com
650-646-2193
投资者联系方式:
investors@helocorp.com
650-646-2193
SOURCE: Helo Corp.
消息来源:Helo corp。